Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Hinge Health Says Its Service Cuts Human Care Hours 95%, and Runs a 29% Operating Margin in Physical Therapy

by Team Lumida
October 7, 2026
in Equities
Reading Time: 4 mins read
A A
0
Hinge Health Says Its Service Cuts Human Care Hours 95%, and Runs a 29% Operating Margin in Physical Therapy
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Hinge Health says its digital physical therapy service, combining app-based exercises with virtual clinician support, reduces human care team hours by about 95% compared with traditional physical therapy. Operating margin was 29% in the most recent quarter excluding some items, against a target of at least 35%.
  • Revenue is expected to grow roughly 46% this year to about $858 million, with the company targeting ongoing growth of 20% or more annually thereafter. Market capitalisation stands near $8 billion, around nine times expected revenue, with the stock up more than 200% since its May 2025 listing and outpacing the Russell 2000 Health Care Index.
  • Chief executive Daniel Perez said the company expects further acquisitions, particularly in hardware, arguing that too many digital health companies shy away from it. Hinge already sells Enso, a small wearable block intended to relieve pain through electrical pulses.
  • The company recently agreed to buy Cylinder Health, focused on digestive health, for $105 million in cash, and has started a migraine care programme as it expands beyond musculoskeletal conditions. Perez said Hinge is fielding two or three inquiries from digital health companies looking to sell themselves.

What Happened?

The San Francisco-based company plans to combine acquisitions with internal research and development to find new growth avenues, according to Perez speaking to Bloomberg News.

Why It Matters?

The 95% reduction in human care hours is the thesis, and it is the clearest listed example of what AI and automation do to a regulated professional service. This is not software assisting clinicians, it is care delivered almost entirely without them, and the 29% operating margin in physical therapy exists because the labour cost has been removed rather than reduced. Apollo has warned about agents disrupting banking, and legal technology firms are pressuring billable-hour work, but those arguments are mostly prospective. Here the same dynamic appears with audited financials and a market capitalisation attached, which makes it the most concrete evidence available of how far this can go in a licensed field. Investors trying to size the AI labour-substitution theme should study this income statement rather than the forecasts. The hardware strategy sits awkwardly beside the margin target and deserves scrutiny. Devices carry inventory, manufacturing, warranty and regulatory costs, and they structurally dilute software economics, so expanding into hardware while targeting an increase from 29% to 35% operating margin requires the software side to carry considerably more weight. Perez is explicit that this is contrarian, and contrarian can be right, but the margin arithmetic is the thing to watch. The acquisition posture tells you about the sector rather than the company. Receiving inbound approaches from digital health firms wanting to sell, while buying Cylinder for $105 million in cash, indicates private valuations have fallen far enough that a public company with a tripled share price can consolidate cheaply. Using an expensive currency to buy distressed assets is a sound playbook and it also means the sector outside the listed winners is struggling. On valuation, roughly nine times revenue is supported by 46% growth, but the company guides to 20% or more thereafter, which is less than half the current rate. Anyone buying at this multiple is underwriting both the deceleration and the margin expansion.

What Next?

Margin progression from 29% toward the 35% target is the number that matters, particularly as hardware becomes a larger part of the mix. Watch which companies Hinge acquires from the two or three approaches Perez describes, since the prices paid will show how depressed private digital health valuations have become. Revenue growth decelerating from 46% toward the 20% guided range is the expected path, and how smoothly that happens will determine whether the multiple holds. The migraine programme and the Cylinder digestive health acquisition are the tests of whether the model transfers beyond musculoskeletal care, which is the question underlying the entire growth case.

Affected Tickers and Coins: HNGE, TDOC, HIMS

Source: Bloomberg

Previous Post

San Francisco Bans New Data Centers in the City That Houses OpenAI and Anthropic

Next Post

A Firm With a $20 Million Disclosed Fund Is Proposing $1.5 Billion of Venezuelan Mining Investment

Recommended For You

BofA’s Moynihan Says Deals Are Being Pushed Into 2027 as Anthropic’s Blockbuster IPO Crowds Out Smaller Listings

by Team Lumida
13 hours ago
Bank of America Q4 2024 Earnings Analysis

Bank of America CEO Brian Moynihan said some deals are slipping into 2027 as Anthropic’s IPO crowds out smaller listings, though the pipeline is full.

Read more

Take-Two Climbs More Than 3% Ahead of Thursday’s ‘GTA VI’ Launch, as Jefferies Reiterates a $300 Target and Says the Game ‘Is Just the Beginning’

by Team Lumida
13 hours ago

Take-Two rose more than 3% ahead of GTA VI’s Nov. 19 launch, as Jefferies kept a $300 target and preorders topped 12 million.

Read more

Buffett Gives Away $5.5 Billion of Berkshire Stock as Shares Rally More Than 19% This Quarter Against the S&P 500’s 1.2% Decline

by Team Lumida
13 hours ago
Lumida Wealth Whale Watch Q2’24 : Value Funds

Warren Buffett donated about $5.5 billion of Berkshire shares to four foundations as the stock hits records while the S&P 500 slips.

Read more

L3Harris Falls 4% After the Administration Ties the Nationwide FAA Ground Stop to Its Fiber Work, as About 18,000 US Flights Are Canceled and Airline Stocks Slip

by Team Lumida
13 hours ago

L3Harris fell 4% after officials tied Friday’s FAA ground stop to its maintenance work, as airlines tallied about 18,000 cancellations.

Read more

Nvidia Faces a $109 Billion Revenue Test in Kress’s First Call as Interim CEO, With the Stock Down Six Straight Weeks and Morgan Stanley Cutting Data-Center Estimates About 10%

by Team Lumida
13 hours ago

Nvidia reports Tuesday with Street eyeing $109.1 billion in revenue as interim CEO Kress faces China, neocloud and succession questions.

Read more

Petition to Reinstate Jensen Huang Tops 160,000 Signatures as Altimeter and Atreides Urge Nvidia’s Board to Keep His Return on the Table

by Team Lumida
21 hours ago
Nvidia Defies US Controls: $12 Billion AI Chip Sales in China

A petition backing Jensen Huang's return to Nvidia has topped 160,000 signatures, and major holders want the board to weigh all options.

Read more

Cisco Shares Drop 6% a Day After the Company Beats Estimates and Raises Hyperscaler AI-Infrastructure Revenue Guidance to $9 Billion

by Team Lumida
3 days ago

Cisco fell 6% on Friday, a day after beating estimates and raising its hyperscaler AI-infrastructure revenue outlook to $9 billion.

Read more

Apple Hits an Intraday Record of $360.80 and Tops $5.2 Trillion as Bernstein Calls It the ‘Costco’ of Tech and Keeps a $380 Target

by Team Lumida
3 days ago

Apple rose nearly 1% to an intraday record of $360.80 and a value above $5.2 trillion, as Bernstein kept an outperform rating and a $380 target.

Read more

Supreme Court Agrees to Hear Robinhood’s Challenge to a 2021 IPO Omission Lawsuit That Also Names Goldman and J.P. Morgan

by Team Lumida
3 days ago

The Supreme Court agreed to hear Robinhood’s challenge to a lawsuit over omitted 2021 IPO data, a case that also names Goldman Sachs and J.P. Morgan.

Read more

GOP Leaders Summon Huang to Testify and Threaten Subpoenas, as Nvidia’s Board Says It Has Not Yet Chosen a CEO Search Firm

by Team Lumida
3 days ago

Lawmakers summoned Jensen Huang to testify and threatened subpoenas, as Nvidia’s board said it has not yet chosen a firm to search for a permanent CEO.

Read more
Next Post
A Firm With a $20 Million Disclosed Fund Is Proposing $1.5 Billion of Venezuelan Mining Investment

A Firm With a $20 Million Disclosed Fund Is Proposing $1.5 Billion of Venezuelan Mining Investment

US Stock Futures Little Changed Friday After Thursday’s Post-Fed Rally; Asian Markets Gain on Rate Clarity, AI Narrative Intact

Non-Dealers Took a Record 97.5% of the 10-Year Auction at 5.3%, the Strongest Evidence Yet That Real Money Is Buying

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Trump-Xi Summit Yields $60B ’30-for-30′ Tariff Framework; $30B US Goods, $30B China Goods; Trade Deficit Down 40% to $140B; Ceasefire Extended 2 Months to Jan 10; Rare Earths Unresolved; Meetings Nov/Dec

Trump-Xi Summit Yields $60B ’30-for-30′ Tariff Framework; $30B US Goods, $30B China Goods; Trade Deficit Down 40% to $140B; Ceasefire Extended 2 Months to Jan 10; Rare Earths Unresolved; Meetings Nov/Dec

September 28, 2026
Apollo Grabs Major Stake in Deutsche Bank’s $3 Billion Debt Deal

Apollo Is Finalizing a Nearly 10% Stake in Mubadala Capital, Deepening Its Abu Dhabi Ties With a Manager Overseeing More Than $755 Billion

October 26, 2026
Is BlackRock the New Leader in Alternative Investments?

Why BlackRock Is Weathering the Private Credit Storm Better Than Its Rivals

April 9, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018